A detailed history of Apg Asset Management N.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Apg Asset Management N.V. holds 2,305,407 shares of BMY stock, worth $119 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,305,407
Previous 3,182,709 27.56%
Holding current value
$119 Million
Previous $173 Million 44.53%
% of portfolio
0.16%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $35.3 Million - $46.5 Million
-877,302 Reduced 27.56%
2,305,407 $95.7 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $8.11 Million - $9.2 Million
-169,071 Reduced 5.04%
3,182,709 $173 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $8.27 Million - $9.87 Million
170,557 Added 5.36%
3,351,780 $172 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $15.1 Million - $16.9 Million
-260,390 Reduced 7.57%
3,181,223 $185 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $22.1 Million - $24.6 Million
347,120 Added 11.22%
3,441,613 $220 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $17.7 Million - $20 Million
-268,799 Reduced 7.99%
3,094,493 $214 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $132 Million - $156 Million
1,926,918 Added 134.15%
3,363,292 $242 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $53,303 - $31.5 Million
-410,029 Reduced 22.21%
1,436,374 $104 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $84.8 Million - $93.4 Million
1,167,356 Added 171.91%
1,846,403 $136 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $3.87 Million - $4.64 Million
62,996 Added 10.23%
679,047 $44.6 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $7.65 Million - $8.92 Million
-142,600 Reduced 18.8%
616,051 $33.8 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $9.95 Million - $11.7 Million
-168,200 Reduced 18.15%
758,651 $38.7 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $14.7 Million - $16 Million
-237,079 Reduced 20.37%
926,851 $52.2 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $60.3 Million - $67.8 Million
-1,016,317 Reduced 46.61%
1,163,930 $62.5 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $71.8 Million - $81.4 Million
-1,244,101 Reduced 36.33%
2,180,247 $111 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $20.6 Million - $22.9 Million
-359,104 Reduced 9.49%
3,424,348 $176 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $27.3 Million - $31.9 Million
497,205 Added 15.13%
3,783,452 $198 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $74.8 Million - $109 Million
1,611,682 Added 96.24%
3,286,247 $183 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $38.5 Million - $56 Million
-830,333 Reduced 33.15%
1,674,565 $71.2 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $98.5 Million - $129 Million
2,002,108 Added 398.2%
2,504,898 $143 Million
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $1.62 Million - $1.92 Million
-37,846 Reduced 7.0%
502,790 $23.4 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $50.6 Million - $55.9 Million
-1,133,929 Reduced 67.71%
540,636 $21.5 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $34.7 Million - $41.4 Million
-769,749 Reduced 31.49%
1,674,565 $71.2 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $5.34 Million - $6.92 Million
-109,500 Reduced 4.29%
2,444,314 $111 Million
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $2.17 Million - $2.45 Million
-39,400 Reduced 1.52%
2,553,814 $136 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $23.3 Million - $29 Million
460,325 Added 21.58%
2,593,214 $123 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $6.88 Million - $7.92 Million
114,800 Added 5.69%
2,132,889 $110 Million
Q4 2017

Jan 24, 2018

BUY
$59.94 - $65.35 $24.2 Million - $26.4 Million
403,600 Added 25.0%
2,018,089 $103 Million
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $89.2 Million - $103 Million
1,614,489
1,614,489 $103 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $110B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.